Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

ASX 200 morning report – CXO, SIG & TLX shares in focus

President Biden delivered his annual State of the Union address during the session, with strong commentary around Ukraine and targeted investment into domestic manufacturing capacity supporting US futures and ultimately pushing the S&P/ASX 200 (ASX: XJO) up another 0.3%.

Despite the positive day, seven of the 11 major sectors were down with cyclical companies in property and the banking sector the hardest hit.

ANZ Banking Group (ASX: ANZ) fell 2.2% and Vicinity Centres (ASX: VCX) dropped 1.9% as a falling bond yield is expected to crimp their profit margins and rent increases.

Fund managers were also on the nose with Janus Henderson Group CDI (ASX: JHG) and Pendal Group Ltd (ASX: PDL) down 7% and 4%, respectively.

Economy bouncing back

The news came with a positive backdrop on the economy, with GDP growth reaching 3.4% and bringing Australia back where it was before the pandemic; a stunning result given immigration is all but gone.

Household spending was the primary driver, up 6.3% as Victoria and NSW were released from Delta lockdowns, offsetting a weakening in property and private investment. Even a 28% fall in the value of iron ore exports wasn’t enough to slow the positive result, with a 39% jump in coal offsetting the decline.

Lithium hopeful jumps on Tesla deal

Lithium hopeful Core Lithium Ltd (ASX: CXO) gained 15.2% after announcing that Tesla (NASDAQ: TSLA) had entered a contract to deliver 110,000 tonnes of concentrate at market prices beginning in 2023.

Sigma upgrades on COVID tests

Sigma Healthcare Ltd (ASX: SIG) gained 2% after the company upgraded earnings guidance, confirming that profits would be 10-15% better than last year, an improvement on its announcement in December that it would be falling by 10% for the financial year. The improved performance was put down to the massive demand for Rapid Antigen Tests in 2022.

Telix cancels capital raise

Telix Pharmaceuticals Ltd (ASX: TLX) has pulled its $175 million capital raise via a Share Purchase Plan after the share price tanked in the January sell-off.

After raising capital from institutions at $7.70 per share, it was retail investors’ turns to provide the company with fresh equity. Yet with the Telix share price having fallen to $5.16 today, there was no benefit at all in buying new equity at a premium to market, hence the forced cancellation of the offer.

ASX 200 today

Looking ahead, the ASX 200 is set to open higher this morning after all three US benchmarks delivered more than 1% gains overnight. To find out more, check out my US stock market report.

The Golden Rules of Investing

We might be experts in retirement, but with combined financial advice experience of 35+ years, we’ve nearly seen it all. 

In mid-2023, our senior team at Wattle Partners Financial Planning put the finishing touches on a brand-new report “The Golden Rules of Investing“.

In this free report, we outline the key principles that determine all of the portfolio construction and investment decisions of Wattle Partners. Collated over decades, this paper should be seen as a work-in-progress, constantly under review in light of the ever-evolving nature of markets. 

You’ll find the free report on my Author page. Simply click the button below to view the Golden Rules.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.


At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Powered by

Wattle Partners is a financial advice firm, servicing clients around Australia, specialising in retirement planning (pre and post retirement). 

Skip to content